Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation

Journal of Clinical Investigation

Volumn 118, Issue 11, 2008, Pages 3598-3608

  Frey, Norbert ^a   Frank, Derk ^a   Lippl, Stefanie ^a   Kuhn, Christian ^a   Kögler, Harald ^b   Barrientos, Tomasa ^c,e   Rohr, Claudia ^a   Will, Rainer ^a   Müller, Oliver J ^a   Weiler, Hartmut ^d   Bassel Duby, Rhonda ^c   Katus, Hugo A ^a   Olson, Eric N ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d BLOOD RESEARCH INSTITUTE   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALSARCIN 2; MUSCLE PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXERCISE; FAST MUSCLE; MOUSE; MUSCLE CELL; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RUNNING; SKELETAL MUSCLE; SLOW MUSCLE FIBER; WEIGHT REDUCTION;

ANIMALS; CALCINEURIN; CARRIER PROTEINS; CELL LINE; GENES, REPORTER; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE PROTEINS; MYOBLASTS; NFATC TRANSCRIPTION FACTORS; PHYSICAL CONDITIONING, ANIMAL;

EID: 55849135238     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI36277     Document Type: Article

References (42)

1. Bassel-Duby, R., and Olson, E.N. 2006. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 75:19-37.
2. Dolmetsch, R.E., Lewis, R.S., Goodnow, C.C., and Healy, J.I. 1997. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature. 386:855-858.
3. Bassel-Duby, R., and Olson, E.N. 2003. Role of calcineurin in striated muscle: development, adaptation, and disease. Biochem. Biophys. Res. Commun. 311:1133-1141.
4. Schiaffino, S., Sandri, M., and Murgia, M. 2007. Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda). 22:269-278.
5. Chin, E.R., et al. 1998. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 12:2499-2509.
6. Delling, U., et al. 2000. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol. Cell. Biol. 20:6600-6611.
7. Naya, F.J., et al. 2000. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J. Biol. Chem. 275:4545-4548.
8. Parsons, S.A., et al. 2004. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J. Biol. Chem. 279:26192-26200.
9. Frey, N., Richardson, J.A., and Olson, E.N. 2000. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 97:14632-14637.
10. Frank, D., Kuhn, C., Katus, H.A., and Frey, N. 2006. The sarcomeric Z-disc: a nodal point in signalling and disease. J. Mol. Med. 84:446-468.
11. Takada, F., et al. 2001. Myozenin: an alpha-actinin-and gamma-filamin-binding protein of skeletal muscle Z lines. Proc. Natl. Acad. Sci. U. S. A. 98:1595-1600.
12. Faulkner, G., et al. 2000. FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle. J. Biol. Chem. 275:41234-41242.
13. Frey, N., and Olson, E.N. 2002. Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins. J. Biol. Chem. 277:13998-14004.
14. Gontier, Y., et al. 2005. The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins. J. Cell. Sci. 118:3739-3749.
15. Frey, N., et al. 2004. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. Med. 10:1336-1343.
16. Frank, D., et al. 2007. Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy. Circulation. 116:2587-2596.
17. Glass, D.J. 2003. Molecular mechanisms modulating muscle mass. Trends Mol. Med. 9:344-350.
18. Arany, Z., et al. 2007. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5:35-46.
19. Booth, F.W., and Thomason, D.B. 1991. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol. Rev. 71:541-585.
20. Schiaffino, S., and Reggiani, C. 1996. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol. Rev. 76:371-423.
21. Molkentin, J.D., et al. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:215-228.
22. Davies, K.J., et al. 2007. Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J. 21:3023-3028.
23. Yang, J., et al. 2000. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ. Res. 87:E61-E68.
24. Crabtree, G.R., and Olson, E.N. 2002. NFAT signaling: choreographing the social lives of cells. Cell. 109(Suppl.):S67-S79.
25. Stupka, N., Schertzer, J.D., Bassel-Duby, R., Olson, E.N., and Lynch, G.S. 2007. Calcineurin-A alpha activation enhances the structure and function of regenerating muscles after myotoxic injury. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R686-R694.
26. Abbott, K.L., Friday, B.B., Thaloor, D., Murphy, T.J., and Pavlath, G.K. 1998. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol. Biol. Cell. 9:2905-2916.
27. Sakuma, K., et al. 2003. Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2. Acta Neuropathol. 105:271-280.
28. Lin, J., et al. 2002. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 418:797-801.
29. Wang, Y.X., et al. 2004. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2:e294.
30. Arany, Z., et al. 2005. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 1:259-271.
31. Parsons, S.A., Wilkins, B.J., Bueno, O.F., and Molkentin, J.D. 2003. Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice. Mol. Cell. Biol. 23:4331-4343.
32. Dapp, C., Schmutz, S., Hoppeler, H., and Fluck, M. 2004. Transcriptional reprogramming and ultrastructure during atrophy and recovery of mouse soleus muscle. Physiol. Genomics. 20:97-107.
33. Talmadge, R.J., et al. 2004. Calcineurin activation influences muscle phenotype in a muscle-specific fashion. BMC Cell Biol. 5:28.
34. MacArthur, D.G., et al. 2007. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat. Genet. 39:1261-1265.
35. Wu, H., et al. 2002. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science. 296:349-352.
36. Wu, H., et al. 2001. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J. 20:6414-6423.
37. Potthoff, M.J., et al. 2007. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest. 117:2459-2467.
38. Kim, M., et al. 2008. Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances performance. Mol. Cell. Biol. 28:3600-3609.
39. North, K.N., et al. 1999. A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat. Genet. 21:353-354.
40. Yang, N., et al. 2003. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet. 73:627-631.
41. North, K.N., and Beggs, A.H. 1996. Deficiency of a skeletal muscle isoform of alpha-actinin (alpha-actinin-3) in merosin-positive congenital muscular dystrophy. Neuromuscul. Disord. 6:229-235.
42. Bush, E., et al. 2004. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 101:2870-2875.